- Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in ChinaLi, Jian; Zhang, Jun; Zhang, Yanqiao; Qiu, Haibo; Zhou, Yanbing; Zhou, Yongjian; Zhang, Xinhua; Zhou, Ye; Zhu, Yuping; Li, Yong; Wang, Ming; Shen, Kuntang; Tao, Kaixiong; Wu, Xin; Wang, Haijiang; Zhang, Bo; Ling, Jiayu; Ye, Yingjiang; Wu, Xingye; Qu, Hongyan; Ma, Yue; Jiao, Xuelong; Zheng, Hualong; Jin, Jiejie; Liu, Zhuo; Tan, Ming; Fang, Yong; Zhang, Peng; Zhang, Nan; Lei, Cheng; Cai, Zhaolun; Liang, Bin; Peng, Zhangyan; Huang, Zhao; Dong, Juan; Shen, Lin*European Journal of Cancer, 2024, 196: 113439.
- A Case of Gastrointestinal Stromal Tumor of the Small Intestine with Peritoneal Metastasis Successfully Treated with Imatinib MesylateToshihisa, Kimura; Katsuji, Sawai; Tamotsu, Togawa; Makoto, Ishida; Nobuhiko, Ueda; Toshiharu, Sawa; Akio, Yamaguchi; Yasunori, SatoJapanese Journal of Gastroenterological Surgery, 2012, 45(5): 530-536.
- Safety, Feasibility, and Efficacy of Capecitabine Maintenance in Patients With Advanced Gastric Cancer: A Retrospective StudyEren Orhan Onder; Ozturk Mehmet Akif; Sonmez Ozlem Uysal; Oyan BasakAmerican Journal of Therapeutics, 2016, 23(6).
会议论文
Efficacy and safety of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2 multicenter, randomized, openlabel study in China.
1被引18阅读
